Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of First-Line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas.
Okuma Y, Nomura S, Sakakibara-Konishi J, Tsukita Y, Murakami S, Hosomi Y, Tambo Y, Kogure Y, Yoshioka H, Tamiya M, Ninomiya K, Iwama E. Okuma Y, et al. Among authors: hosomi y. Clin Lung Cancer. 2024 Feb 8:S1525-7304(24)00013-5. doi: 10.1016/j.cllc.2024.02.002. Online ahead of print. Clin Lung Cancer. 2024. PMID: 38413246
S-1 is an active anticancer agent for advanced thymic carcinoma.
Okuma Y, Shimokawa T, Takagi Y, Hosomi Y, Iguchi M, Okamura T, Shibuya M. Okuma Y, et al. Among authors: hosomi y. Lung Cancer. 2010 Dec;70(3):357-63. doi: 10.1016/j.lungcan.2010.09.004. Epub 2010 Oct 15. Lung Cancer. 2010. PMID: 20951466
Clinical outcomes with chemotherapy for advanced thymic carcinoma.
Okuma Y, Hosomi Y, Takagi Y, Sasaki E, Hishima T, Maeda Y, Shibuya M, Okamura T. Okuma Y, et al. Among authors: hosomi y. Lung Cancer. 2013 Apr;80(1):75-80. doi: 10.1016/j.lungcan.2012.12.012. Epub 2013 Jan 11. Lung Cancer. 2013. PMID: 23313005 Free article.
188 results